Antidiabetic medication and risk of dementia in patients with type 2 diabetes: a nested case control study
64 In contrast with prior anti-obesity medications, concerns about suicide intention have not been confirmed for GLP-1 RA therapy
Its use must always be carefully considered by a healthcare provider, particularly when combined with other medications due to the potential for drug interactions
Besides diabetes and obesity management, GLP-1 drugs have shown many other potential benefits including: Lowering blood pressure Improving lipid disorders Improving fatty liver disease Reducing cardiovascular risk Decreases inflammation Reducing risk of kidney disease It is common for patients starting GLP-1 therapy to experience side effects during the first few weeks, including nausea, vomiting, headache, dizziness, and diarrhea
All of these medications provide such great weight loss results because they make maintaining a calorie-deficient diet substantially easier for patients as intense cravings and frequency of binge eating are drastically reduced when the appetite is lacking